Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL choleste...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4637f21548d947e5b1af8ade15841430 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4637f21548d947e5b1af8ade15841430 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4637f21548d947e5b1af8ade158414302021-12-02T17:19:15ZRegulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling10.1038/s41598-021-97327-y2045-2322https://doaj.org/article/4637f21548d947e5b1af8ade158414302021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97327-yhttps://doaj.org/toc/2045-2322Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and tumor LDLR might accelerate oncogenic processes by determining whether increased LDLR expression and cholesterol uptake are associated with the activation of the epidermal growth factor receptor (EGFR) signaling pathway in triple negative breast cancer (TNBC) cell lines. EGF stimulation of MDA-MB-468 (MDA468) cells activated p44/42MAPK (MAPK), increased expression of LDLR, and fluorescent LDL cholesterol uptake. However, stimulation of MDA-MB-231 (MDA231) cells with EGF did not lead to increased expression of LDLR despite inducing phosphorylation of EGFR. Inhibition of MAPK using UO126 in MDA231 cells reduced LDLR expression, and in MDA468 cells, UO126 impaired the LDLR increase in response to EGF. MDA468 cells exposed to the transcription inhibitor, Actinomycin, prior to treatment with EGF showed reduced degradation of LDLR mRNA compared to vehicle-treated cells. Our results suggest that the EGF-associated increase in LDLR protein expression is cell line-specific. The common pathway regulating LDLR expression was MAPK in both TNBC cell lines.Tiffany ScullyNathan KaseEmily J. GallagherDerek LeRoithNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tiffany Scully Nathan Kase Emily J. Gallagher Derek LeRoith Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
description |
Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and tumor LDLR might accelerate oncogenic processes by determining whether increased LDLR expression and cholesterol uptake are associated with the activation of the epidermal growth factor receptor (EGFR) signaling pathway in triple negative breast cancer (TNBC) cell lines. EGF stimulation of MDA-MB-468 (MDA468) cells activated p44/42MAPK (MAPK), increased expression of LDLR, and fluorescent LDL cholesterol uptake. However, stimulation of MDA-MB-231 (MDA231) cells with EGF did not lead to increased expression of LDLR despite inducing phosphorylation of EGFR. Inhibition of MAPK using UO126 in MDA231 cells reduced LDLR expression, and in MDA468 cells, UO126 impaired the LDLR increase in response to EGF. MDA468 cells exposed to the transcription inhibitor, Actinomycin, prior to treatment with EGF showed reduced degradation of LDLR mRNA compared to vehicle-treated cells. Our results suggest that the EGF-associated increase in LDLR protein expression is cell line-specific. The common pathway regulating LDLR expression was MAPK in both TNBC cell lines. |
format |
article |
author |
Tiffany Scully Nathan Kase Emily J. Gallagher Derek LeRoith |
author_facet |
Tiffany Scully Nathan Kase Emily J. Gallagher Derek LeRoith |
author_sort |
Tiffany Scully |
title |
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
title_short |
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
title_full |
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
title_fullStr |
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
title_full_unstemmed |
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling |
title_sort |
regulation of low-density lipoprotein receptor expression in triple negative breast cancer by egfr-mapk signaling |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/4637f21548d947e5b1af8ade15841430 |
work_keys_str_mv |
AT tiffanyscully regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling AT nathankase regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling AT emilyjgallagher regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling AT derekleroith regulationoflowdensitylipoproteinreceptorexpressionintriplenegativebreastcancerbyegfrmapksignaling |
_version_ |
1718381023880806400 |